- Singapore Exchange (SGX) reported Feb 2024 operating data; while the securities trading data remained weak, the derivatives volume continued to meet estimates.
- SGX announced plans to boost dividend by a mid-single-digit percentage in the medium term.
- - Read this at SGinvestors.io -
Singapore remained the second most actively traded equities market in ASEAN in February.
- SDAV in February came in at S$1.25bn (+13% y-o-y, +34% m-o-m). Total securities turnover value was S$25bn (+13% y-o-y, +22% m-o-m) despite fewer trading days compared to January.
- - Read this at SGinvestors.io -
- SGX also saw the listing of Singapore Institute of Advanced Medicine Holdings on the Catalist board.
- Despite the recent month’s strength, year-to-date securities turnover value and SDAV are 8% and 10% below the same period last year. The implied FY24F SDAV, based on the year-to-date data, was 14% below our estimate. As such, we lower our FY24 SDAV estimate by ~12%.
YTD derivatives data is tracking estimates.
- Read more at SGinvestors.io.
Shekhar Jaiswal RHB Securities Research | https://www.rhbgroup.com/ 2024-03-18
Previous report by RHB:
2024-02-15 Singapore Exchange (SGX) - Derivatives Volume Continues To Improve.
Price targets by other brokers at SGX Target Prices.
Listing of research reports at SGX Analyst Reports.
Relevant links:
SGX Share Price History,
SGX Announcements,
SGX Dividends & Corporate Actions,
SGX News Articles
